NoonanJAEhmkeDA. Associated noncardiac malformations in children with congenital heart disease. J Pediatr1963;63:468–470.
2.
NoonanJA. Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease. Am J Dis Child1968;116:373–380.
3.
JefferiesJLBelmontJWPignatelliRTowbinJACraigenWJ. PTPN11 mutation associated with aortic dilation and hypertrophic cardiomyopathy in a pediatric patient with Noonan syndrome. Pediatr Cardiol2010;31:114–116.
4.
MendezHMOpitzJM. Noonan syndrome: A review. Am J Med Genet1985;21:493–506.
5.
FernandezGarcia FFreirePavon CBenitoPerez LPerezCabrera ACarasaVesga JCVillalobosJL. [Ulrich-Noonan syndrome associated with coarctation of the aorta. Presentation of a new case]. Med Clin (Barc)1983;81:278–279.
6.
ZarabiMMieckowskiGCMazerJ. Cystic hygroma associated with Noonan's syndrome. J Clin Ultrasound1983;11:398–400.
TanakaYMasunoMIwamotoH. Noonan syndrome and cavernous hemangioma of the Brain. Am J Med Genet1999; 82:212–214.
9.
AllansonJE. Noonan syndrome. J Med Genet1987;24:9–13.
10.
ColeRB. Noonan's syndrome: A historical perspective. Pediatrics1980;66:468–469.
11.
SharlandMMorganMSmithGBurchMPattonMA. Genetic counselling in Noonan syndrome. Am J Med Genet1993;45: 437–440.
12.
TartagliaMMehlerELGoldbergR. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet2001;29:465–468.
13.
RobertsAEArakiTSwansonKD. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet2007;39:70–74.
14.
TartagliaMPennacchioLAZhaoC. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet2007;39:75–79.
15.
PanditBSarkozyAPennacchioLA. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet2007;39:1007–1012.
16.
RazzaqueMANishizawaTKomoikeY. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet2007;39:1013–1017.
17.
SchubbertSZenkerMRoweSL. Germline KRAS mutations cause Noonan syndrome. Nat Genet2006;38:331–336.
18.
CirsteaICKutscheKDvorskyR. A restricted spectrum of NRAS mutations causes Noonan syndrome. Nat Genet2010; 42:27–29.
19.
CordedduVDi SchiaviEPennacchioLA. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet2009; 41:1022–1026.
20.
De LucaABottilloISarkozyA. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome. Am J Hum Genet2005;77:1092–1101.
21.
PerezBMechinaudFGalambrunC. Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia. J Med Genet2010; 47:686–691.
22.
MartinelliSDe LucaAStellacciE. Heterozygous germline mutations in the CBL tumor–suppressor gene cause a Noonan syndrome-like phenotype. Am J Hum Genet2010;87:250–257.
23.
TartagliaMGelbBDZenkerM. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab2011;25: 161–179.
24.
CarcavillaASantomeJLPintoI. LEOPARD syndrome: A variant of Noonan syndrome strongly associated with hypertrophic cardiomyopathy. Rev Esp Cardiol (Engl Ed)2013;66:350–356.
25.
DigilioMCContiESarkozyA. Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet2002;71:389–394.
BremsHChmaraMSahbatouM. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet2007;39:1120–1126.
28.
AokiYNiihoriTKawameH. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet2005; 37:1038–1040.
29.
SharlandMBurchMMcKennaWMPatonMA. A clinical study of Noonan syndrome. Arch Dis Child1992;67:178–183.
30.
OkuyamaANishimotoNYoshiokaT. Gonadal findings in cryptorchid boys with Noonan's phenotype. Eur Urol1981;7: 274–277.
31.
SasagawaINakadaTKubotaYSawamuraTTatenoTIshigookaM. Gonadal function and testicular histology in Noonan's syndrome with bilateral cryptorchidism. Arch Androl1994;32:135–140.
32.
ElsawiMMPryorJPKlufioGBarnesCPattonMA. Genital tract function in men with Noonan syndrome. J Med Genet1994; 31:468–470.
33.
MarcusKASweepCGvan der BurgtINoordamC. Impaired Sertoli cell function in males diagnosed with Noonan syndrome. J Pediatr Endocrinol Metab2008;21:1079–1084.
34.
Ankarberg-LindgrenCWestphalODahlgrenJ. Testicular size development and reproductive hormones in boys and adult males with Noonan syndrome: A longitudinal study. Eur J Endocrinol.2011;165:137–144.
35.
NistalMPaniaguaRPallardoLF. Testicular biopsy and hormonal study in a male with Noonan's syndrome. Andrologia1983; 15:415–425.
36.
MeschedeDFrosterUGGullottaFNieschlagE. Reproductive failure in a patient with neurofibromatosis-Noonan syndrome. Am J Med Genet1993;47:346–351.
37.
VerloesAGuidiOFredericJLambotteC. Noonan and Klinefelter syndromes in a child. Am J Med Genet1987;27:727–728.
38.
DinopoulosAPapadopoulouAMantaP. Coinheritance of Noonan syndrome and Becker muscular dystrophy. Neuromuscul Disord2010;20:61–63.
39.
DerbentMOncelYTokelK. Clinical and hematologic findings in Noonan syndrome patients with PTPN11 gene mutations. Am J Med Genet A2010;152A:2768–2774.
40.
HasleH. Malignant diseases in Noonan syndrome and related disorders. Horm Res2009;72(suppl 2):8–14.
41.
KratzCPRapisuwonSReedHHasleHRosenbergPS. Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes. Am J Med Genet C Semin Med Genet2011;157C:83–89.
AggarwalAKrishnanJKwartAPerryD. Noonan's syndrome and seminoma of undescended testicle. South Med J2001;94: 432–434.
44.
BarnicoatAJBonneauJLBoydE. Down syndrome with partial duplication and del (21) syndrome: Study protocol and call for collaboration. Study I: Clinical assessment. Clin Genet1996;49: 20–27.
45.
BairdPASadovnickAD. Life expectancy in Down syndrome. J Pediatr1987;110:849–854.
46.
KimSTChaYBParkJMGyeMC. Successful pregnancy and delivery from frozen-thawed embryos after intracytoplasmic sperm injection using round-headed spermatozoa and assisted oocyte activation in a globozoospermic patient with mosaic Down syndrome. Fertil Steril2001;75:445–447.
47.
PradhanMDalalAKhanFAgrawalS. Fertility in men with Down syndrome: A case report. Fertil Steril2006;86: 1765.e1–1765.e3.
48.
ZuhlkeCThiesUBraulkeIReisASchirrenC. Down syndrome and male fertility: PCR-derived fingerprinting, serological and andrological investigations. Clin Genet1994;46:324–326.
49.
HsiangYHBerkovitzGDBlandGLMigeonCJWarrenAC. Gonadal function in patients with Down syndrome. Am J Med Genet1987;27:449–458.
50.
ChewGHutsonJM. Incidence of cryptorchidism and ascending testes in trisomy 21: A 10 year retrospective review. Pediatr Surg Int2004;20:744–747.
51.
GoedeJWeijermanMEBroersCJde WinterJPvan der Voort-DoedensLMHackWW. Testicular volume and testicular microlithiasis in boys with Down syndrome. J Urol2012;187: 1012–1017.
52.
MercerESBroeckerBSmithEAKirschAJScherzHC, C AM. Urological manifestations of Down syndrome. J Urol2004;171: 1250–1253.
53.
VachonLFareauGEWilsonMGChanLS. Testicular microlithiasis in patients with Down syndrome. J Pediatr2006; 149:233–236.
54.
GrinsponRPBedecarrasPBalleriniMG. Early onset of primary hypogonadism revealed by serum anti-Müllerian hormone determination during infancy and childhood in trisomy 21. Int J Androl2011;34:e487–498.
55.
CampbellWALowtherJMcKenzieIPriceWH. Serum gonadotrophins in Down's syndrome. J Med Genet1982;19:98–99.
56.
HawliYNasrallahMFuleihanEl-Hajj G. Endocrine and musculoskeletal abnormalities in patients with Down syndrome. Nat Rev Endocrinol2009;5:327–334.
57.
SakadamisAAngelopoulouNMatziariCPapameletiouVSouftasV. Bone mass, gonadal function and biochemical assessment in young men with trisomy 21. Eur J Obstet Gynecol Reprod Biol2002;100:208–212.
58.
SasagawaINakadaTHashimotoT. Hormone profiles and contralateral testicular histology in Down's syndrome with unilateral testicular tumor. Arch Androl1993;30:93–98.
59.
HasenJBoyarRMShapiroLR. Gonadal function in trisomy 21. Horm Res1980;12:345–350.
60.
StearnsPEDroulardKESahharFH. Studies bearing on fertility of male and female mongoloids. Am J Ment Defic1961;65:37–41.
61.
CoolsMDropSLWolffenbuttelKPOosterhuisJWLooijengaLH. Germ cell tumors in the intersex gonad: Old paths, new directions, moving frontiers. Endocr Rev2006;27:468–484.
62.
XavierACGeYTaubJW. Down syndrome and malignancies: A unique clinical relationship: A paper from the 2008 william beaumont hospital symposium on molecular pathology. J Mol Diagn2009;11:371–380.
63.
IshidaMHodoharaKOkabeH. Mediastinal seminoma occurring in Down syndrome. J Pediatr Hematol Oncol2012;34:387–388.
64.
DadaRKumarRKucheriaK. A 2-year-old baby with Downs syndrome, cryptorchidism and testicular tumour. Eur J Med Genet2006;49:265–268.
65.
DexeusFHLogothetisCJChongCSellaAOgdenS. Genetic abnormalities in men with germ cell tumors. J Urol1988;140: 80–84.
66.
DieckmannKPRubeCHenkeRP. Association of Down's syndrome and testicular Cancer. J Urol1997;157:1701–1704.
67.
IchiyanagiOSasagawaIKubotaYYaguchiHSuzukiYNakadaT. Down's syndrome associated with seminoma in undescended testis. Scand J Urol Nephrol1998;32:365–367.
68.
JohannissonRGroppAWinkingHCoerdtWRehderHSchwingerE. Down's syndrome in the male. Reproductive pathology and meiotic studies. Hum Genet1983;63:132–138.
69.
KamidonoSTakadaKIshigamiJFurumotoMUranoY. Giant seminoma of undescended testis in Down syndrome. Urology1985;25:637–640.
70.
KurodaNAmanoSShiotsuT. Mixed testicular germ cell tumor in an adult with cryptorchidism and Down's syndrome. APMIS2007;115:1292–1295.
71.
MannJRPearsonDBarrettARaafatFBarnesJMWallendszusKR. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer1989;63: 1657–1667.
72.
Russell-EggittIMClaytonPTCoffeyRKrissATaylorDSTaylorJF. Alstrom syndrome. Report of 22 cases and literature review. Ophthalmology1998;105:1274–1280.
73.
SatgeDSascoAJCureHLeducBSommeletDVekemansMJ. An excess of testicular germ cell tumors in Down's syndrome: Three case reports and a review of the literature. Cancer1997;80: 929–935.
74.
SleijferSKoopsHSvan der GraafWT. Successful treatment on an out-patient basis of a patient with Down's syndrome and disseminated testicular seminoma. Neth J Med1996;48:89–91.
75.
HouJWWangTR. Double aneuploidy with Down's-Klinefelter's syndrome. J Formos Med Assoc1996;95:350–352.
76.
ShenZZouCCShangSQJiangKW. Down-Klinefelter syndrome (48,XXY,+21) in a child with congenital heart disease: Case report and literature review. Intern Med2012;51:1371–1374.
77.
CoerdtWRehderHGausmannIJohannissonRGroppA. Quantitative histology of human fetal testes in chromosomal disease. Pediatr Pathol1985;3:245–259.
78.
RossesAD. Myotonic dystrophy. In: RosenbergRNPrusinerSBDiMauroS, eds. The Molecular and Genetic Basis of Neurological Disease. Boston, MA: Butterworth; 1993:633–646.
79.
FutterweitWMechanickJI. Myotonic dystrophy presenting as male infertility: A case report. Int J Fertil1987;32:142–144.
80.
CaugheyJESaucierG. Endocrine aspects of dystrophia myotonica. Brain1962;85:711–732.
81.
DruckerWDBlancWARowlandLPGrumbachMMChristyNP. The testis in myotonic muscular dystrophy: A clinical and pathologic study with a comparison with the Klinefelter's syndrome. J Clin Endocr1963;23:59–75.
82.
SteinertH. Uber das klinische und anatomische Bild des Mukelschwunds der Myotoniker. Dtsch Z Nervenheilk1909;37:58–62.
83.
DaoTNMathieuJBouchardJPDe BraekeleerM. Fertility in myotonic dystrophy in Saguenay-Lac-St-Jean: A historical perspective. Clin Genet1992;42:234–239.
84.
MahadevanMTsilfidisCSabourinL. Myotonic dystrophy mutation: An unstable CTG repeat in the 39 untranslated region of the gene. Science1992;255:1253–1255.
85.
HarleyHGRundleSAMacMillanJC. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet1993;52: 1164–1174.
86.
RedmanJBFenwickRGJr.FuYHPizzutiACaskeyCT. Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. JAMA1993;269: 1960–1965.
87.
TsilfidisCMacKenzieAEMettlerGBarceloJKornelukRG. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat Genet1992;1: 192–195.
88.
RanumLPDayJW. Myotonic dystrophy: Clinical and molecular parallels between myotonic dystrophy type 1 and type 2. Curr Neurol Neurosci Rep2002;2:465–470.
89.
BrunnerHGBruggenwirthHTNillesenW. Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM). Am J Hum Genet1993;53:1016–1023.
90.
VazquezJAPiniesJAMartulPDe los RiosAGatzambideSBusturiaMA. Hypothalamic-pituitary-testicular function in 70 patients with myotonic dystrophy. J Endocrinol Invest1990;13: 375–379.
91.
HortasMLCastillaJAGilMT. Decreased sperm function of patients with myotonic muscular dystrophy. Hum Reprod2000;15: 445–448.
92.
AntoniniGClemenziABucciE. Hypogonadism in DM1 and its relationship to erectile dysfunction. J Neurol2011;258: 1247–1253.
93.
HarperPPennyRFoleyTPJrMigeonCJBlizzardRM. Gonadal function in males with myotonic dystrophy. J Clin Endocrinol Metab1972;35:852–856.
94.
PericSNisicTMilicevM. Hypogonadism and erectile dysfunction in myotonic dystrophy type 1. Acta Myol2013;32: 106–109.
95.
BergKSkreH. Possible linkage between the Marinesco–Sjogren syndrome and hypergonadotropic hypogonadism. Cytogenet Cell Genet1976;16:271–274.
96.
MastrogiacomoIBonanniGMenegazzoE. Clinical and hormonal aspects of male hypogonadism in myotonic dystrophy. Ital J Neurol Sci1996;17:59–65.
97.
OrngreenMCArlien-SoborgPDunoMHertzJMVissingJ. Endocrine function in 97 patients with myotonic dystrophy type 1. J Neurol2012;259:912–920.
98.
FebresFScagliaHLiskerR. Hypothalamic-pituitary-gonadal function in patients with myotonic dystrophy. J Clin Endocrinol Metab1975;41:833–840.
99.
SarkarPSPaulSHanJReddyS. Six5 is required for spermatogenic cell survival and spermiogenesis. Hum Mol Genet2004;13:1421–1431.
100.
KunejTTeranNZornBPeterlinB. CTG amplification in the DM1PK gene is not associated with idiopathic male subfertility. Hum Reprod2004;19:2084–2087.
101.
MarchiniCLonigroRVerrielloLPellizzariLBergonziPDamanteG. Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy. Clin Genet2000;57:74–82.
102.
HauserWAulitzkyWBaltaciSFrickJ. Increasing infertility in myotonia dystrophica Curschmann-Steinert. A case report. Eur Urol1991;20:341–342.
103.
FiolMEDalyRFOsborneRH. Dystrophia myotonica in a 47, XXY male. Neurology1975;25:472–476.
104.
RollandYMazieresBLarocheM. [Steinert disease associated with Klinefelter's syndrome]. Rev Neurol (Paris)1999;155:229–230.
105.
FinstererJStollbergerC. The heart in human dystrophinopathies. Cardiology2003;99:1–19.
106.
DaviesKENowakKJ. Molecular mechanisms of muscular dystrophies: Old and new players. Nat Rev Mol Cell Biol2006;7: 762–773.
107.
BartonER. Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle. Am J Physiol Cell Physiol2006;290:C411–C419.
108.
BiggarWDKlamutHJDemacioPCStevensDJRayPN. Duchenne muscular dystrophy: Current knowledge, treatment, and future prospects. Clin Orthop Relat Res2002:88–106.
109.
ErvastiJM. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta2007; 1772:108–117.
110.
HoffmanEPFischbeckKHBrownRH. Characterization of dystrophin in muscle–biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med1988;318:1363–1368.
111.
KasparRWAllenHDMontanaroF. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy. J Am Acad Nurse Pract2009;21:241–249.
112.
KimUKChaeJJLeeSHLeeCCNamkoongY. Molecular diagnosis of Duchenne/Becker muscular dystrophy by polymerase chain reaction and microsatellite analysis. Mol Cells2002;13: 385–388.
113.
StrehleEMStraubV. Recent advances in the management of Duchenne muscular dystrophy. Arch Dis Child2015;100: 1173–1177.
114.
OdelCruz Guzman RGarciaChavez ALRodriguez-CruzM. Muscular dystrophies at different ages: Metabolic and endocrine alterations. Int J Endocrinol2012;2012:485376.
115.
ZeitounOKetelsenUPWolffGMullerCRKorinthenbergR. Rare combination of Becker muscular dystrophy and Klinefelter's syndrome in one patient. Brain Dev1997;19:359–361.
116.
LundbergPO. Hereditary myopathy, oligophrenia, cataract, skeletal abnormalities and hypergonadotropic hypogonadism; a new syndrome. Eur Neurol1973;10:261–280.
117.
LuomaPMelbergARinneJO. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: Clinical and molecular genetic study. Lancet2004;364: 875–882.
118.
PagnamentaATTaanmanJWWilsonCJ. Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma. Hum Reprod2006;21: 2467–2473.
119.
MelbergAArnellHDahlN. Anticipation of autosomal dominant progressive external ophthalmoplegia with hypogonadism. Muscle Nerve1996;19:1561–1569.
120.
MalandriniAVillanovaMPiomboniP. Ultrastructural sperm abnormalities and cerebellar atrophy: Does a correlation exist? Report of two cases without endocrine hypogonadism. J Submicrosc Cytol Pathol1993;25:371–375.
121.
HaradaTPinedaLLNakanoA. Ataxia and male sterility (AMS) mouse. A new genetic variant exhibiting degeneration and loss of cerebellar Purkinje cells and spermatic cells. Pathol Int2003;53:382–389.
122.
BrionJPGuilleminotJNunezJ. Dendritic and axonal distribution of the microtubule-associated proteins MAP2 and tau in the cerebellum of the nervous mutant mouse. Brain Res Dev Brain Res.1988;44:221–232.
123.
PetersLLBirkenmeierCSBronsonRT. Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. J Cell Biol1991;114:1233–1241.
124.
Braga-NetoPMartinsMCSantos-NetoD. Hypergonadotropic hypogonadism and cerebellar ataxia: An unusual association. Arq Neuropsiquiatr2010;68:132–134.
125.
KwonDYParkMH. Hypergonadotropic hypogonadism in spinocerebellar ataxia type 2: A case report. J Sex Med2009;6: 1779–1782.
126.
SkreHBassoeHHBergKFrovigAG. Cerebellar ataxia and hypergonadotropic hypogonadism in two kindreds. Chance concurrence, pleiotropism or linkage?Clin Genet1976;9:234–244.
127.
MillinoCFaninMVettoriA. Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy. BMC Med2009;7:14.
128.
RichertJRAntelJPCanaryJJMaxtedWCGroothuisD. Adult onset spinal muscular atrophy with atrophic testes: Report of two cases. J Neurol Neurosurg Psychiatry1986;49:606–608.
129.
Hausmanowa-PetrusewiczIBorkowskaJJanczewskiZ. X-linked adult form of spinal muscular atrophy. J Neurol1983;229:175–188.
130.
BachratiCZHicksonID. Analysis of the DNA unwinding activity of RecQ family helicases. Methods Enzymol2006;409:86–100.
131.
LindorNMDevriesEMMichelsVV. Rothmund-Thomson syndrome in siblings: Evidence for acquired in vivo mosaicism. Clin Genet1996;49:124–129.
132.
SinghDKAhnBBohrVA. Roles of RECQ helicases in recombination based DNA repair, genomic stability and aging. Biogerontology2009;10:235–252.
133.
MohagheghPHicksonID. Premature aging in RecQ helicase-deficient human syndromes. Int J Biochem Cell Biol2002;34: 1496–1501.
134.
MorimotoWKanekoHIsogaiKKasaharaKKondoN. Expression of BLM (the causative gene for Bloom syndrome) and screening of Bloom syndrome. Int J Mol Med2002;10:95–99.
135.
JainDHuiPMcNamaraJSchwartzDGermanJReyes-MugicaM. Bloom syndrome in sibs: First reports of hepatocellular carcinoma and Wilms tumor with documented anaplasia and nephrogenic rests. Pediatr Dev Pathol2001;4:585–589.
136.
SatoAMishimaMNagaiA. Solution structure of the HRDC domain of human Bloom syndrome protein BLM. J Biochem.2010;148:517–525.
137.
MartinRHRademakerAGermanJ. Chromosomal breakage in human spermatozoa, a heterozygous effect of the Bloom syndrome mutation. Am J Hum Genet1994;55:1242–1246.
138.
KauliRPrager-LewinRKaufmanHLaronZ. Gonadal function in Bloom's syndrome. Clin Endocrinol (Oxf)1977;6:285–289.
AnbariKKIerardi-CurtoLASilberJS. Two primary osteosarcomas in a patient with Rothmund-Thomson syndrome. Clin Orthop Relat Res2000:213–223.
141.
StincoGGovernatoriGMattighelloPPatroneP. Multiple cutaneous neoplasms in a patient with Rothmund-Thomson syndrome: Case report and published work review. J Dermatol.2008;35:154–161.
142.
VennosEMCollinsMJamesWD. Rothmund-Thomson syndrome: Review of the world literature. J Am Acad Dermatol1992; 27:750–762.
143.
WangLLLevyMLLewisRA. Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients. Am J Med Genet2001;102:11–17.
144.
WernerSRPrahaladAKYangJHockJM. RECQL4-deficient cells are hypersensitive to oxidative stress/damage: Insights for osteosarcoma prevalence and heterogeneity in RothmundThomson syndrome. Biochem Biophys Res Commun2006;345: 403–409.
145.
KitaoSOhsugiIIchikawaKGotoMFuruichiYShimamotoA. Cloning of two new human helicase genes of the RecQ family: Biological significance of multiple species in higher eukaryotes. Genomics1998;54:443–452.
146.
WangLLWorleyKGannavarapuAChintagumpalaMMLevyMLPlonSE. Intron-size constraint as a mutational mechanism in Rothmund-Thomson syndrome. Am J Hum Genet2002;71: 165–167.
147.
MartinGMOshimaJGrayMDPootM. What geriatricians should know about the Werner syndrome. J Am Geriatr Soc1999; 47:1136–1144.
148.
KudlowBAKennedyBKMonnatRJJr. Werner and Hutchinson-Gilford progeria syndromes: Mechanistic basis of human progeroid diseases. Nat Rev Mol Cell Biol2007;8:394–404.
149.
HuangSLeeLHansonNB. The spectrum of WRN mutations in Werner syndrome patients. Hum Mutat2006; 27:558–567.
150.
EpsteinCJMartinGMSchultzALMotulskyAG. Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore)1966;45:177–221.
151.
GoldsteinS. Human genetic disorders that feature premature onset and accelerated progression of biological aging. In: SchneiderLL, ed. The Genetics of Aging. New York, NY: Plenum Press; 1978: 171–224.
152.
GotoM. Werner's syndrome: From clinics to genetics. Clin Exp Rheumatol2000;18:760–766.
153.
HsuJJKamath–LoebASGlickE. Werner syndrome gene variants in human sarcomas. Mol Carcinog2010;49: 166–174.
154.
YuCEOshimaJFuYH. Positional cloning of the Werner's syndrome gene. Science1996;272:258–262.
155.
HamdaniMEl KettaniARaisL. [Cockayne's syndrome with unusual retinal involvement (report of one family)]. J Fr Ophtalmol2000;23:52–56.
156.
LandingBHSugarmanGDixonLG. Eccrine sweat gland anatomy in cockayne syndrome: A possible diagnostic aid. Pediatr Pathol1983;1:349–353.
157.
MdeArenas-Sordo LHernandez-ZamoraEMontoya-PerezLAAldape-BarriosBC. Cockayne's syndrome: A case report. Literature review. Med Oral Patol Oral Cir Bucal2006;11:E236–E238.
158.
WeidenheimKMDicksonDWRapinI. Neuropathology of Cockayne syndrome: Evidence for impaired development, premature aging, and neurodegeneration. Mech Ageing Dev.2009; 130:619–636.
159.
PriceVHOdomRBWardWHJonesFT. Trichothiodystrophy: Sulfur-deficient brittle hair as a marker for a neuroectodermal symptom complex. Arch Dermatol1980;116:1375–1384.
160.
TayCH. Ichthyosiform erythroderma, hair shaft abnormalities, and mental and growth retardation. A new recessive disorder. Arch Dermatol1971;104:4–13.
McCuaigCMarcouxDRasmussenJEWernerMMGentnerNE. Trichothiodystrophy associated with photosensitivity, gonadal failure, and striking osteosclerosis. J Am Acad Dermatol1993;28:820–826.
163.
Morice-PicardFCario-AndreMRezvaniHLacombeDSarasinATaiebA. New clinico-genetic classification of trichothiodystrophy. Am J Med Genet A2009;149A:2020–2030.
164.
DevriendtKVan den BergheHFrynsJP. Alopecia-mental retardation syndrome associated with convulsions and hypergonadotropic hypogonadism. Clin Genet1996;49:6–9.
165.
Al-SemariABohlegaS. Autosomal-recessive syndrome with alopecia, hypogonadism, progressive extra-pyramidal disorder, white matter disease, sensory neural deafness, diabetes mellitus, and low IGF1. Am J Med Genet A2007;143a:149–160.
166.
VisootsakJRosnerBDykensE. Clinical and behavioral features of patients with Borjeson-Forssman-Lehmann syndrome with mutations in PHF6. J Pediatr2004;145:819–825.
167.
LowerKMTurnerGKerrBA. Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome. Nat Genet2002;32:661–665.
168.
VossAKGambleRCollinC. Protein and gene expression analysis of Phf6, the gene mutated in the Borjeson-Forssman-Lehmann syndrome of intellectual disability and obesity. Gene Expr Patterns2007;7:858–871.
169.
WeberFTFriasJLJuliusRLFelmanAH. Primary hypogonadism in the Borjeson-Forssman-Lehmann syndrome. J Med Genet1978;15:63–66.
170.
ChaoMMToddMAKontnyU. T-cell acute lymphoblastic leukemia in association with Borjeson-Forssman-Lehmann syndrome due to a mutation in PHF6. Pediatr Blood Cancer2010;55: 722–724.
171.
KomiyamaANonakaIHirayamaK. Muscle pathology in Marinesco-Sjogren syndrome. J Neurol Sci1989;89:103–113.
172.
MarinescoGDraganescoSVasiliuD. Nouvelle maladie familiale caracterisee pare une cataracte congenitale et un arret du development somato-neuro-psychique. Encephale1931;26:97–109.
173.
SjogrenT. Hereditary congenital spinocerebellar ataxia accompanied by congenital cataract and oligophrenia; a genetic and clinical investigation. Confin Neurol1950;10:293–308.
174.
AnttonenAKMahjnehIHamalainenRH. The gene disrupted in Marinesco-Sjogren syndrome encodes SIL1, an HSPA5 cochaperone. Nat Genet2005;37:1309–1311.
175.
FranceschiMParmigianiFZamproniPCairoliGCanalN. Richards-Rundle syndrome, cochleovestibular dysfunction and neurofibromatosis in a family. J Neurol1984;231:11–13.
176.
HowesJShimizuYFeigeMJHendershotLM. C-terminal mutations destabilize SIL1/BAP and can cause Marinesco-Sjogren syndrome. J Biol Chem2012;287:8552–8560.
177.
SenderekJKriegerMStendelC. Mutations in SIL1 cause Marinesco-Sjogren syndrome, a cerebellar ataxia with cataract and myopathy. Nat Genet2005;37:1312–1314.
178.
MahjnehIAnttonenAKSomerM. Myopathy is a prominent feature in Marinesco-Sjogren syndrome: A muscle computed tomography study. J Neurol2006;253:301–306.
179.
McLaughlinJFPagonRAWeinbergerEHaasJE. Marinesco-Sjogren syndrome: Clinical and magnetic resonance imaging features in three children. Dev Med Child Neurol1996;38: 636–644.
180.
FujitakeJKomatsuYHatayaY. A case of Marinesco-Sjogren syndrome: MRI observations of skeletal muscles, bone metabolism, and treatment with testosterone and risedronate. Intern Med2011;50:145–149.
181.
RobinGJonardSVuillaumeIDevosDDewaillyD. [Hypogonadotropic hypogonadism discovered in a patient with cerebellar ataxia]. Ann Endocrinol (Paris)2005;66:545–551.
182.
RobinowMSilvermanFNSmithHD. A newly recognized dwarfing syndrome. Am J Dis Child1969;117:645–651.
183.
LeePADanishRKMazurTMigeonCJ. Micropenis. III. Primary hypogonadism, partial androgen insensitivity syndrome, and idiopathic disorders. Johns Hopkins Med J1980;147:175–181.
184.
WangBSinhaTJiaoKSerraRWangJ. Disruption of PCP signaling causes limb morphogenesis and skeletal defects and may underlie Robinow syndrome and brachydactyly type B. Hum Mol Genet2011;20:271–285.
185.
OrbakZOrbakRKaraCKavrutF. Differences in dental and bone maturation in regions with or without hemihypertrophy in two patients with Russell-Silver syndrome. J Pediatr Endocrinol Metab2005;18:701–710.
186.
AngehrnVZachmannMPraderA. Silver–Russell syndrome. Observations in 20 patients. Helv Paediatr Acta1979;34:297–308.
187.
TassoniPTomesaniABalsamoA. [The Silver-Russel syndrome. Endocrinological study of 5 cases]. Minerva Pediatr1982;34:905–920.
188.
Abu-AmeroSMonkDFrostJPreeceMStanierPMooreGE. The genetic aetiology of Silver-Russell syndrome. J Med Genet2008;45:193–199.
189.
EggermannTSchonherrNJagerS. Segmental maternal UPD(7q) in Silver-Russell syndrome. Clin Genet2008;74:486–489.
190.
EggermannT. Russell-Silver syndrome. Am J Med Genet C Semin Med Genet2010;154c:355–364.
191.
WeinsteinRLKlimanBScullyRE. Familial syndrome of primary testicular insufficiency with normal virilization, blindness, deafness and metabolic abnormalities. N Engl J Med1969;281: 969–977.
192.
LubinskyMS. Cataracts and testicular failure in three brothers. Am J Med Genet1983;16:149–152.
193.
AbediniSSKahriziKBehjatiFBanihashemiSFiroozabadiGhasemi SNajmabadiH. Mutational screening of ARX gene in Iranian families with X-linked intellectual disability. Arch Iran Med2012;15:361–365.
194.
de Souza Gestinari-DuarteRSantos-ReboucasCBPimentelMM. Mutational screening of ARX gene in Brazilian males with mental retardation of unknown etiology. J Hum Genet2006;51:737–740.
195.
KitamuraKYanazawaMSugiyamaN. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet2002;32:359–369.
196.
DobynsWBBerry-KravisEHavernickNJHoldenKRViskochilD. X-linked lissencephaly with absent corpus callosum and ambiguous genitalia. Am J Med Genet1999;86:331–337.
197.
OzdemirOMCaglarMKocyigitADundarNOSangunODundarB. Primary hypogonadism in a case with XLAG syndrome. J Pediatr Endocrinol Metab2012;25:1161–1163.